What’s going on with nitrosamines? Naiffer Romero from the USP walks us through frequently asked questions.

A campaign to vaccinate children against polio in Gaza has begun, but success will depend on the vital role of the pharmaceutical industry.

A recent US-based study discovered a new compound that could enhance naloxone’s ability to fend off more potent opioids.

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

The deadline for the US Drug Supply Chain Security Act is approaching.

Our special series eBook covers some of the hottest topics in cell and gene therapy including closed processing and more.

The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.

Drug shortages are everywhere. We speak with Vimala Raghavendran at the US Pharmacopeia to get the full picture.

With open minds and open sources, the future is foundational – and bright.

Vaccine manufacturers invited to take on mpox challenges